Glazer Capital discloses stakes in three companies involved in takeover situations
Glazer Capital disclosed holdings in Irish Continental Group, Rotork and Spire Healthcare, with a 3.73% stake in the Irish company and derivative trades in the two UK names.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Glazer Capital, LLC has filed mandatory Form 8.3 disclosures covering three companies that are subject to takeover procedures. According to Irish Continental Group's published filing, the fund holds 5,538,138 shares with a €0.065 nominal value, equal to 3.73% of the capital. On 26 October it bought 5,201 shares at €7.96 each.
At Rotork, the fund holds cash-settled derivatives tied to 23,186,563 shares, or 2.84%. On 26 October it increased a long position through a total return swap covering 22,179 reference shares at 4.92 pounds. At Spire Healthcare, cash-settled derivatives total 10,160,900 shares, or 2.52%, and the fund reduced a long position by 41,117 reference shares at 2.49 pounds.
why it matters
Form 8.3 applies to holders of 1% or more of a company's securities when that company is in an offer period. Such filings show how large investors are positioning in target companies, but on their own they do not signal whether a deal will happen or on what terms.
tags
instruments
sources
- REG - Glazer Capital, LLC Irish Continental - Form 8.3 — Irish Continental Group plc, 27 October 2026 at 15:25 UTC
- REG - Glazer Capital, LLC Rotork PLC - Form 8.3 — Rotork plc, 27 October 2026 at 15:25 UTC
- REG - Glazer Capital, LLC Spire Healthcare Grp - Form 8.3 — Spire Healthcare Group plc, 27 October 2026 at 15:25 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗